title: Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy.
abstract: Acute liver failure and metabolic liver disorder animal models have demonstrated that hepatocytes transplanted into the liver or spleen survive and participate in the liver repopulation process, and recent studies have documented the usefulness of hepatocyte transplantation in humans. However, despite the promising cell therapy, there are still many restrictions, such as the shortage of donor human livers and the limited lifespan and the functional insufficiency of primary cultured hepatocytes. The immortalized and highly differentiated human hepatocyte could provide an unlimited supply of transplantable cells. In this study, we established an efficient and highly differentiated immortalized human hepatocyte line for bioartificial liver and hepatocyte transplantation research. Hepatocytes isolated from the liver of a 25 year old, brain dead male were transfected with pcDNA3.1 (-) recombinant plasmid containing the genes encoding simian virus 40 (SV40) large tumor antigen. One of the hepatocyte clones, HepLL, displayed highly differentiated liver functions with immortalized characteristics and was selected with a 700-300 microg/ml of G418 technique in 42 days. To characterize this immortalized cell line for cell therapy in the near future, HepLL cells were studied with immunohistochemistry, reverse transcription-polymerase chain reactions, immunoblotting, and tumorigenicity tests. The results revealed that HepLL cells displayed morphologic characteristics of liver parenchymal cells, secreted albumin, synthesized urea and glycogen, and expressed liver enriched functional markers, but there were no tumorigenic qualities after transplantation into severe combined immunodeficiency mice. Thus this immortalized human hepatocyte line is expected to be a useful tool for studying the functions of differentiated human hepatocyte and a promising strategy to resolve the shortages of donor organs and the limits of primary human hepatocyte for transplantation and bioartificial liver support systems.
authors.affiliation: Department of Infectious Disease, 1st Affiliated Hospital, College of Medicine, Zhejiang University, Key Lab of Infectious Disease of Ministry of Health, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Li
authors.forename: Lan-Juan
authors.initials: LJ
authors.lastname: Li
authors.forename: Hong-Cui
authors.initials: HC
authors.lastname: Cao
authors.forename: Guo-Ping
authors.initials: GP
authors.lastname: Sheng
authors.forename: Hai-Ying
authors.initials: HY
authors.lastname: Yu
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
authors.forename: Ji-Fang
authors.initials: JF
authors.lastname: Sheng
mesh_terms: D000418:Albumins / Q000378:metabolism; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics*; D002454:Cell Differentiation; D002461:Cell Line, Transformed; D049109:Cell Proliferation; D002478:Cells, Cultured; D022781:Hepatocytes / Q000637:transplantation*; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D016513:Mice, SCID; D012333:RNA, Messenger / Q000032:analysis; D013539:Simian virus 40 / Q000276:immunology*; D014508:Urea / Q000378:metabolism
chemical_list: D000418:Albumins; D000952:Antigens, Polyomavirus Transforming; D012333:RNA, Messenger; D014508:Urea